Key result
Clozapine initiation is linked to suspected myocarditis or cardiomyopathy in ~10% of patients.
Why the study?
The incidence and clinical features of clozapine-related myocarditis and cardiomyopathy remain uncertain, with variable reported rates and limited data on management and rechallenge.
What is the incidence and diagnostic likelihood of clozapine-related myocarditis and cardiomyopathy in patients initiated on clozapine?
Population
94 patients initiated on clozapine over 3 years in a Brisbane-based psychiatric service
Comparison
Patients with suspected clozapine-related myocarditis or cardiomyopathy vs others on clozapine
Design
Observational case series with multidisciplinary panel review
Follow-up
3 years
Authors
Loading...
Supports closer cardiac surveillance with clozapine initiation; leaves open true incidence and rechallenge safety.
Observational (n=94)
No
What is the incidence and diagnostic likelihood of clozapine-related myocarditis and cardiomyopathy in patients initiated on clozapine?
This case series highlights an unexpectedly high incidence of clozapine-related myocarditis in a single center and suggests that clozapine rechallenge may be a viable option for some patients.
Reinders et al. (2004) conducted an observational in Clozapine-related myocarditis and cardiomyopathy (n=94). Clozapine was evaluated on Clozapine-related myocarditis or cardiomyopathy. Clozapine initiation was associated with suspected myocarditis or cardiomyopathy in 9 of 94 patients (9.6%), representing an unexpectedly high incidence in this Australian psychiatric service.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: